Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagopian, W. A.
Right arrow Articles by Lernmark, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagopian, W. A.
Right arrow Articles by Lernmark, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 42, Issue 4 631-636, Copyright © 1993 by American Diabetes Association

ARTICLES

Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase

WA Hagopian, B Michelsen, AE Karlsen, F Larsen, A Moody, CE Grubin, R Rowe, J Petersen, R McEvoy and A Lernmark
University of Washington, Department of Medicine, Seattle 98195.

Glutamic acid decarboxylase autoantibodies may aid in rapid screening strategies predicting IDDM before clinical onset. Rat islets contain GAD65 and GAD67 autoantibody targets, but human islets express only GAD65, now confirmed by direct immunoprecipitation from radiolabeled rat and human islets. Because human IDDM involves beta-cell-specific autoimmunity, we tested 190 new IDDM patients and 51 healthy control subjects for antibodies to recombinant human islet GAD65, rat islet GAD67, or human insulinoma/cerebellum GAD67, each expressed separately in hamster fibroblasts. By using immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and densitometric fluorogram scanning, 132 of 190 (70%) of new IDDM patients had GAD65 autoantibodies, whereas only 17 of 190 (9%) had antibodies to rat GAD67 (P < 0.001). Of healthy control subjects, 2 of 51 (3.9%) and 1 of 51 (1.9%) had antibodies to GAD65 and GAD67, respectively. All 17 GAD67 antibody-positive patients also had GAD65 antibodies; 14 of 17 with greater GAD65 than GAD67 index. Control studies showed comparable reactivity between recombinant rat and human GAD67 and between different subcellular preparations of recombinant GAD67 of either species. In conclusion, only GAD65 is expressed in human islets, the autoantibody response is primarily to this isoform, and GAD67 antibodies add little to IDDM detection.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
S.-H. Lee, H. Lee, J.-S. Park, H. Choi, K.-Y. Han, H.-S. Seo, K.-Y. Ahn, S.-S. Han, Y. Cho, K.-H. Lee, et al.
A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles
FASEB J, May 1, 2007; 21(7): 1324 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. S Ronkainen, S. Hoppu, S. Korhonen, S. Simell, R. Veijola, J. Ilonen, O. Simell, and M. Knip
Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
Eur. J. Endocrinol., October 1, 2006; 155(4): 633 - 642.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
W. E. Winter, N. Harris, and D. Schatz
Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes
Clin. Diabetes, October 1, 2002; 20(4): 183 - 191.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Hampe, L. P. Hammerle, L. Bekris, E. Örtqvist, I. Kockum, O. Rolandsson, M. Landin-Olsson, C. Törn, B. Persson, and A. Lernmark
Recognition of Glutamic Acid Decarboxylase (GAD) by Autoantibodies from Different GAD Antibody-Positive Phenotypes
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4671 - 4679.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. A. Myers, J. M. Davies, J. C. Tong, J. Whisstock, M. Scealy, I. R. Mackay, and M. J. Rowley
Conformational Epitopes on the Diabetes Autoantigen GAD65 Identified by Peptide Phage Display and Molecular Modeling
J. Immunol., October 1, 2000; 165(7): 3830 - 3838.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-C. Hsu, C. Thomas, W. Chen, K. M. Davis, T. Foos, J. L. Chen, E. Wu, E. Floor, J. V. Schloss, and J.-Y. Wu
Role of Synaptic Vesicle Proton Gradient and Protein Phosphorylation on ATP-mediated Activation of Membrane-associated Brain Glutamate Decarboxylase
J. Biol. Chem., August 20, 1999; 274(34): 24366 - 24371.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. T. Azar, H. Tamim, H. N. Beyhum, M. Z. Habbal, and W. Y. Almawi
Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease
Clin. Vaccine Immunol., May 1, 1999; 6(3): 306 - 310.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Y. Almawi, H. Tamim, and S. T. Azar
T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1497 - 1502.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Hampe, E. Örtqvist, O. Rolandsson, M. Landin-Olsson, C. Törn, A. Ågren, B. Persson, D. B. Schranz, and A. Lernmark
Species-Specific Autoantibodies in Type 1 Diabetes
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 643 - 648.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1993 by the American Diabetes Association.